Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Timothy, Ingall"'
Autor:
Michael E. Christiansen, Timothy Ingall, Edward C. Lew, Ramesh K. Ramanathan, Harshita R. Paripati
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 2, Pp 317-320 (2016)
Ramucirumab is an antiangiogenesis agent targeting the vascular endothelial growth factor receptor-2 (VEGFR-2), approved to treat advanced gastric and colon cancer. In clinical trials, it was shown to cause a small increase in arterial thromboembolis
Externí odkaz:
https://doaj.org/article/0eab7bd6c74a4d41a53477980d24efb7
Publikováno v:
Mayo Clinic proceedings. 84(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8387888faa12d3af88d2fe9743058a27
https://pubmed.ncbi.nlm.nih.gov/19797780
https://pubmed.ncbi.nlm.nih.gov/19797780
Autor:
Timothy, Ingall
Publikováno v:
Journal of insurance medicine (New York, N.Y.). 36(2)
In the United States, 700,000 strokes, responsible for 165,000 deaths, occur each year. Worldwide, stroke is the 2nd leading cause of death. Stroke is a major health problem; and as the population ages, its significance will grow. This paper reviews
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::562ba3e4c424d1accfd76453a2a2e987
https://pubmed.ncbi.nlm.nih.gov/15301227
https://pubmed.ncbi.nlm.nih.gov/15301227